Uterine Fibroid Embolization (UFE) is a minimally invasive procedure that shrinks fibroids by blocking their blood supply, ...

Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

The FDA approves the Embrace Hydrogel Embolic System, offering a groundbreaking treatment for hypervascular tumors in ...

Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced ...

Instylla announced today that it received FDA premarket approval (PMA) for its flagship Embrace hydrogel embolic system (HES) ...

Uterine fibroids affect most women, but our understanding is just now catching up as new research is debunking old myths and ...

The global transcatheter embolization and occlusion (TEO) devices market is set for rapid growth, driven by increasing preference for minimally invasive procedures in oncology, neurology, and other ...

Peripheral vascular embolization solution developer Instylla announced today that it appointed Sean Boyle as its new CEO.

Embolx, a developer of microcatheters for targeted embolization procedures, announced the market release of its ...

“This morning, First Lady Melania Trump underwent an embolization procedure to treat a benign kidney condition. The procedure was successful and there were no complications,” the statement read.

Since we began performing uterine artery embolization for fibroids, we have received numerous direct inquiries from women, their husbands, and their primary care physicians. We were initially ...